DAIC

FEBRUARY 9, 2024

Physicians in the Smidt Heart Institute at Cedars-Sinai have pioneered using a catheter-based approach to treat patients with tricuspid valve disease. The first 100 minimally invasive tricuspid procedures were done as part of the TRISCEND II clinical trial. Image by Getty. Image by Getty. Eduardo Marbán, MD, PhD.

Tricuspid 105

Tricuspid Open-Heart Surgery Interventional Cardiology Bicuspid/Mitral 105

DAIC

APRIL 25, 2024

milla1cf Thu, 04/25/2024 - 17:21 April 25, 2024 — Atlantic Health System ’s Morristown Medical Center treated the first patient in New Jersey using Edwards Lifesciences EVOQUE tricuspid valve replacement, the first transcatheter therapy to receive U.S. According to National Institutes of Health an estimated 1.6 million people in the U.S.

Tricuspid 111

Tricuspid Quality of Life Hospital Nursing 111

DAIC

FEBRUARY 2, 2024

Photo: Edwards Lifesciences milla1cf Fri, 02/02/2024 - 09:33 February 2, 2024 — Edwards Lifesciences Corporation announced the company’s EVOQUE tricuspid valve replacement system is the first transcatheter therapy to receive U.S. Food and Drug Administration (FDA) approval for the treatment of tricuspid regurgitation (TR).

Tricuspid 100

Tricuspid Quality of Life Bicuspid/Mitral Innovation 100

DAIC

APRIL 2, 2024

Food and Drug Administration (FDA) approval of its TriClip, a first-of-its-kind device to repair leaky tricuspid heart valve, for which more than 1.6 are affected by tricuspid regurgitation, 1 which can severely impact quality of life. Abbott has announced U.S million people in the U.S. are estimated to be affected. and Lynn C.

Tricuspid 105

Tricuspid Heart Valves Quality of Life Open-Heart Surgery 105

DAIC

JUNE 5, 2024

The sale enhances Edwards’ balance sheet flexibility for disciplined investments in technologies for aortic, mitral, tricuspid and pulmonic patients, as well as new therapeutic areas for interventional heart failure. Critical Care has made significant contributions to our company and has a long history of pioneering innovation.

Critical Care 105

Critical Care Tricuspid Innovation Bicuspid/Mitral 105

DAIC

MAY 3, 2024

Clinical trials and innovative technology took center stage during the month of April, racking up some record number views. Atlantic Health System’s Morristown Medical Center Treats First Patient in New Jersey with Edwards’ EVOQUE Tricuspid Valve Replacement 3. Here is a look at what DAIC viewers were reading last month: 1.

Blood Pressure 105

Blood Pressure Angioplasty Heart Attack Heart attacks 105

DAIC

DECEMBER 22, 2023

Tricuspid regurgitation (TR) is a common and serious disease for which open heart surgery and symptomatic pharmacologic treatment are the current standard treatment options. Owing to high mortality risk, access to open heart surgery is severely restricted and is not considered an option for most patients with TR.

Tricuspid 59

Tricuspid Pacemaker Heart Valves Open-Heart Surgery 59